Skip to main navigation
Ascendis Pharma Logo
  • Overview
  • Events & Presentations
  • News Releases
    • For Global Media Only
    • For U.S. Media Only
  • Corporate Governance
    • Corporate Governance Documents & Charters
    • Leadership
    • Committee Composition
  • Stock
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
  • Financial & Filings
    • Quarterly Reports
    • SEC Filings
    • Annual General Meeting
    • Extraordinary General Meeting
      • Sept. 9, 2022 EGM
      • Nov. 18, 2021 EGM

Events & Presentations

Events & Presentations

Upcoming Events

More events are coming soon.

Past Events

March 02, 2026 at 11:10 AM EST
TD Cowen 46th Annual Health Care Conference
Click Here for Webcast
March 02, 2026 at 8:00 AM EST
YUVIWEL FDA Approval Call
Click Here for Webcast

Presentations

March 16, 2026
ACMG 2026: ApproaCH Week 104 Data
March 2, 2026
YUVIWEL® (navepegritide) FDA Approval
January 9, 2026
44th Annual J.P. Morgan Healthcare Conference Presentation
January 8, 2026
COACH Trial Topline Week 52 Data
July 12, 2025
ENDO 2025: PaTHway 3-Year Data
June 9, 2025
COACH Trial Interim Topline Week 26 Data
May 15, 2025
ESPE & ESE 2025: ApproaCH 52-Week Bone Morphometry
May 15, 2025
ESPE & ESE 2025: PaTH Forward 4-Year Data
January 12, 2025
43rd Annual J.P. Morgan Healthcare Conference Presentation
September 16, 2024
TransCon™ CNP (navepegritide) ApproaCH Trial Topline Results

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page next ›
  • Last page last »

Shareholder Tools

RSS Feeds
Email Alerts
IR Contact

Footer Corporate Menu

  • TransCon
  • About us
  • Pipeline
  • Patients
  • Investors & News
  • Contact Us

Footer Copyrights Menu

  • Privacy Policy
  • Terms of Use
Ascendis, Ascendis Pharma, Ascendis Pharma logo, the company logo and TransCon are trademarks owned by the Ascendis Pharma group
© March 2026 Ascendis Pharma